DNA binding of TEA/ATTS domain factors is regulated by protein kinase C phosphorylation in human choriocarcinoma cells

The Journal of Biological Chemistry
S W JiangN L Eberhardt

Abstract

Transcription enhancer factor 1 (TEF-1) controls the expression of a diverse set of genes. Previous studies implicated protein kinase C (PKC)-mediated signal transduction in modulating TEF function. We demonstrate that in human choriocarcinoma BeWo cells, the PKC activator 12-O-tetradecanoyl phorbol 13-acetate and PKC inhibitor bisindolylmaleimide reciprocally down- and up-regulate, respectively, TEF-mediated GGAATG core enhancer activity. In vitro TEF-1 phosphorylation with several PKC isozymes and phosphoamino acid analysis confirmed that TEF-1 is a potential PKC substrate. TEF-1.DNA complexes formed by BeWo nuclear extracts are supershifted by phosphoserine- and phosphothreonine- but not phosphotyrosine-specific antibodies, indicating that TEF-1 is phosphorylated in vivo at serine and threonine residues. The TEF-1 phosphorylation domain was localized to the third alpha-helix of the DNA binding domain and adjacent hinge region by phosphopeptide analysis. TEF-1 phosphorylation significantly reduced its DNA binding activity both in vitro and in vivo, providing a possible mechanism for the inhibitory action of PKC. Finally, BeWo cells contained abundant levels of gamma and delta PKC isoforms, and their overexpression resulted in...Continue Reading

References

Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H M ProsserM J Owen
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C C FranklinA S Kraft
Sep 1, 1993·European Journal of Biochemistry·G KochsT F Sarre
Apr 19, 1996·The Journal of Biological Chemistry·S W Jiang, N L Eberhardt
Jul 1, 1996·Molecular and Cellular Biology·S B LarkinC P Ordahl
Feb 28, 1998·The Journal of Biological Chemistry·O CoqueretA Nepveu
Jun 24, 1999·Molecular Endocrinology·S W JiangN L Eberhardt

❮ Previous
Next ❯

Citations

Aug 1, 1989·Biological Reviews of the Cambridge Philosophical Society·C Gans
Jan 1, 1994·Acta Psychiatrica Scandinavica. Supplementum·P Bebbington, L Kuipers
Nov 23, 2006·Zoological Science·Yukihiko YamasakiToru Higashinakagawa
Nov 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Asokan AnbanandamSudha Veeraraghavan
Feb 2, 2006·Molecular and Cellular Endocrinology·Damu R KethidiSubba R Palli
Aug 3, 2004·Genesis : the Journal of Genetics and Development·Hsiao-Huei ChenAlexandre F R Stewart
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·James N TsoporisThomas G Parker
May 3, 2002·The Journal of Biological Chemistry·Tomoji MaedaAlexandre F R Stewart
Jun 20, 2019·Cells·Hyunbin D HuhHyun Woo Park
Sep 27, 2018·Nature Structural & Molecular Biology·Sushant BangruAuinash Kalsotra
Dec 16, 2020·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Richard DrexlerKarl J Oldhafer
Jun 16, 2021·Development·Laura CurreyMichael Piper
May 20, 2021·Molecular Biology of the Cell·Helios Gallego-GutiérrezLorenza González-Mariscal

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.